Nevro Announces USPTO Denies Boston Scientific Petitions for Inter Partes Review of U.S. Patent No. 8,359,102

By: via Benzinga
Nevro Corp. (NYSE: NVRO) announced Monday, that the Patent Trial and Appeals Board (PTAB) at the U.S. Patent and Trademark Office ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.